MARTIN TAMI TILLOTSON (Sr. V.P., Regulatory Affairs) received a stock award from SUPERNUS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/27/2024ACC: 0001104659-24-028269
Officer· Sr. V.P., Regulatory Affairs
Since Feb 2020
-485.00
Net shares
Net seller
$14.1K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
1.25K acquired · 1.74K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.25K
Price / share
—
Trade value
—
% of position
1.5%
2/23/2024
86.17K→87.42K
Common Stock
Direct
Shares
−485.00
Price / share
$29.06
Trade value
$14.09K
% of position
0.6%
2/23/2024
87.42K→86.93K
Total
Net shares
+765.00
Net value
-$14.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/23/2024 | A · Award | +1.25K | — | — | 1.5% | 86.17K | 87.42K |
| Common Stock Direct | 2/23/2024 | F · Tax Withholding | −485.00 | $29.06 | $14.09K | 0.6% | 87.42K | 86.93K |
| Total | +765.00 | -$14.09K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
1.25K shares
Shares
−1.25K
Strike price
Held after
3.75K
Exercisable
—
2/23/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock1.25K shares | 2/23/2024 | D · Disposition | −1.25K | — | 3.75K |